Home › NDC Lookup › RxCUI directory › RxCUI 562847

Betaine 1000 MG Powder for Oral Solution — RxCUI 562847

Name: Betaine 1000 MG Powder for Oral Solution (RxCUI 562847)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 562847 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI562847

Official nameBetaine 1000 MG Powder for Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbetaine anhydrous 1 GM/Scoop Powder for Oral Solution

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)2,821 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Betaine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Homocystinuria is a rare inherited condition where your body can't properly break down an amino acid called homocysteine. It builds up in your blood, which can cause serious health...
What exactly is homocystinuria, and why does betaine help?
Use the measuring scoop that comes with the product to measure out your prescribed amount. Stir it into 4 to 6 ounces of water, juice, milk, or formula until it's completely dissol...
Most people tolerate betaine pretty well. The most common issues are nausea, stomach upset, and diarrhea. Some people notice a change in body odor or an unpleasant taste. These are...

📖 Read our full Betaine guide →

🕸️ Concept Web — How Betaine 1000 MG Powder for Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Betaine 1000 MG Powder for Oral Solution RxCUI 562847 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Betaine 1512 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Cystadane 404967 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Betaine Powder for Oral Solution 1806653 SCDF
- Betaine Oral Powder Product 1295326 SCDG
- Betaine Oral Product 1153573 SCDG
- Betaine Powder for Oral Solution [Cystadane] 1806656 SBDF
- Cystadane Oral Powder Product 1806657 SBDG
- Cystadane Oral Product 1174465 SBDG
- Powder for Oral Solution 1540455 DF
- Oral Powder Product 1294711 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Betaine 1000 MG 1806652 SCDC
- Betaine 1000 MG Powder for Oral Solution [Cystadane] 404539 SBD
- Betaine 1000 MG [Cystadane] 1806655 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Betaine 1000 MG SCDC · 1806652
Betaine Powder for Oral Solution SCDF · 1806653
Betaine Oral Powder Product SCDG · 1295326
Betaine Oral Product SCDG · 1153573

Brand-Name Concepts

Betaine 1000 MG Powder for Oral Solution [Cystadane] SBD · 404539
Betaine 1000 MG [Cystadane] SBDC · 1806655
Betaine Powder for Oral Solution [Cystadane] SBDF · 1806656
Cystadane Oral Powder Product SBDG · 1806657
Cystadane Oral Product SBDG · 1174465
Cystadane BN · 404967

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 562847 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00713-0352-81	180 g in 1 BOTTLE (0713-0352-81)	Betaine	Cosette Pharmaceuticals, Inc.	2023-01-01
52276-0400-01	180 g in 1 BOTTLE (52276-400-01)	Cystadane	Recordati Rare Diseases	2017-04-13
71863-0115-18	180 g in 1 BOTTLE (71863-115-18)	Betaine Anhydrous	Eton Pharmaceuticals, Inc.	2022-01-28

Observed labelers: Cosette Pharmaceuticals, Inc. (1) · Eton Pharmaceuticals, Inc. (1) · Recordati Rare Diseases (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.